Today's Top Stories


Hot Topics


Comment & Analysis »

Pharma Technology Focus – Issue 64

In this issue: Using drugs after their expiration dates have passed, treating lactose intolerance, a closer look at CARB-X’s work on antibacterial R&D, helping nanomedicines reach their...

Pharma Technology Focus – Issue 64
GlobalData Healthcare

With FDA approval secured, Flexion’s Zilretta poised to shake up knee osteoarthritis marketplace

With FDA approval secured, Flexion’s Zilretta poised to shake up knee osteoarthritis marketplace
GlobalData Healthcare

Big pharma fails to challenge UK price controls as court backs NICE

Big pharma fails to challenge UK price controls as court backs NICE
GlobalData Healthcare

FDA has given Mylan’s Copaxone generic the green light

FDA has given Mylan’s Copaxone generic the green light
Lopamudra Roy

September's top stories: Positive opinion for Trelegy Ellipta, Teva agreed to sell assets in women’s health business

September's top stories: Positive opinion for Trelegy Ellipta, Teva agreed to sell assets in women’s health business

Company Releases »

Cadence Acoustic Separator

Pall Corporation
Cadence Acoustic Separator

Dehumidified Air Ensures Quality Hormone Packaging for Orion Pharmaceuticals

Munters Dehumidified Air Ensures Quality Hormone Packaging for Orion Pharmaceuticals

The Innovative Heart of Nordic Life Science

Greater Copenhagen
The Innovative Heart of Nordic Life Science

Human Aqueous Humor Sample Analysis

Notrox Research Human Aqueous Humor Sample Analysis

Pharmaceutical Insights »

Pharmaceutical Industry Reports »

Report: Indonesian pharmaceutical market to be worth $10.11bn by 2021

Report: Indonesian pharmaceutical market to be worth $10.11bn by 2021

Report: Alzheimer’s market set to achieve double-digit growth by 2026

Report: Alzheimer’s market set to achieve double-digit growth by 2026

Report: Russian pharmaceutical market projected to grow to $36.61bn by 2021

Report: Russian pharmaceutical market projected to grow to $36.61bn by 2021

Belimumab: The frontrunner in Lupus clinical trials

Belimumab: The frontrunner in Lupus clinical trials








cachename:HomePagecachekey:rd-1665407042_1729060782_rd-488908060_1460672566_ap1460672566_1729060782_-1100201212